OpenCitations
metadata only
The Bruton Tyrosine Kinase Inhibitor PCI-32765 Blocks B-cell Activation And Is Efficacious In Models Of Autoimmune Disease And B-cell Malignancy
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases#890222
- A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies#911963
- Btk Function In B Cell Development And Response#19608
- T and B Cell Responses in Autoimmune Diseases#160277
- The Bruton's Tyrosine Kinase Gene Is Expressed Throughout B Cell Differentiation, From Early Precursor B Cell Stages Preceding Immunoglobulin Gene Rearrangement Up To Mature B Cell Stages#412848
Record · ID 1148409
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive